Browse All

Current Filters

CLEAR FILTER x

TITLE

Comparison of 2-year Teriflunomide Outcomes between DMT-naive and switch patients with Relapsing MS: subanalysis of the Real-World TERICARE study

Author:Meca Lallana, Jose   Prieto, Jose María   Caminero, Ana Belén   Olascoaga, Javier   Casademont Portell, Rosa   Forner, Mireia   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.003  

Author Institution:Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, Murcia, Spain  Complejo Hospitalario Universitario de Santiago de Compostela, Spain, Santiago de Compostela, Spain  Complejo Asistencial de Ávila, Spain, Ávila, Spain  Hospital Universitario Donostia, Spain, Donostia-San Sebastián, Spain  Sanofi, Barcelona, Spain, Barcelona, Spain  

Improvements in Quality of Life of Patients with Multiple Sclerosis receiving Alemtuzumab in Clinical Practice: LEMVIDA study

Author:Meca Lallana, Jose   Eichau Madueno, Sara   Casanova, Bonaventura   Alvarez Rodríguez, Elena   Pato, Antonio   Toledo, Baldo   Forner, Mireia   

Session Name:P7: MS Therapeutics 1  

Topic:MS and Inflammatory Disease  

Program Number:P7.018  

Author Institution:Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain, Murcia, Spain  Hospital Virgen Macarena, Sevilla, Spain, Sevilla, Spain  Hospital Universitari I Politécnic La Fe, Valencia, Spain, Valencia, Spain  Hospital Álvaro Cunqueiro, Vigo, Spain , Vigo, Spain  Hospital Povisa, Vigo, Spain, Vigo, Spain  Sanofi, Barcelona, Spain, Barcelona, Spain